Hostname: page-component-5db58dd55d-f6s65 Total loading time: 0 Render date: 2026-05-31T03:43:34.841Z Has data issue: false hasContentIssue false

Staging in the treatment of maxillary carcinoma revisited*

Published online by Cambridge University Press:  29 June 2007

Fang-Cheng Liu
Affiliation:
Clinical Professor, Chief of Faculty, Chairman, Department of Otolaryngology, People's Teaching Hospotal, Beijing Medical University, P. R. China Department of Otolaryngology, People' Teaching Hospital, Beijing Medical University, P. R. China. 133 Fu-Nei Street, West City, Beijing, 100034, P. R. China
Marshall strome*
Affiliation:
Associate Professor of Otolaryngology, Harvard Medical School; Otolaryngologist-in-Chief, Beth Israel Hospital and Brigham & Women's Hospital, Boston, Ma. 02215
*
Marshall Strome, M.D., Joint Center for Otolaryngology, 333 Longwood Avenue, Boston, Ma. 02215

Abstract

The site of origin of maxillary sinus carcinoma will not infrequently predetermine the varied neurological signs at presentation. Modifying Ohngren's division, the maxillary sinus can be divided into for quadrants based on anantomical nerve correlates, thus facilitating identification of the primary site. An inclusive classification of maxillary sinus caricinoma based on Broder's grading, site of origin, the TNM classification and the patient's general condition, serves as the basic for a correlative therapeutic regimen.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 1988

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable